Status: Not yet recruiting
Study on the Efficacy of Endoscopic Radiofrequency Treatment in Reducing the Need for Blood Transfusions in GAVE
The aim of the study therefore is to permanently resolve the existence of the bleeding sites caused by Gave and reduce both bleeding episodes and the need for transfusion in such patients applying "Barrx" (trademark) radiofrequency endoscopic ablation technology in selected cohort of patients that will be defined the patient inclusion section.
Participants needed: 80
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de BellisUpdated: Feb 17, 2025
Eligibility criteria
At least 18 years of age [+4]
Alternative causes for iron deficiency anemia (gastro-duodenal erosions and/or u... [+4]